Literature DB >> 20187243

Advances in environmental epidemiology.

Caroline M Tanner1.   

Abstract

Parkinson's disease (PD) is likely due to the combined effects of environment and genes in most cases. Environmental factors inversely associated with PD (or, putative protective factors) include cigarette smoking, use of coffee/caffeine, higher uric acid levels, and anti-inflammatory drug use. Less well-established inverse associations with PD include higher cholesterol levels, statin use, higher dietary vitamin B6, and night shift work. Putative risk factors are pesticide exposure, head trauma, certain occupations, and milk consumption. The pathogenesis of PD may begin decades before motor symptoms. PD may have shared determinants with other neurodegenerative disorders involving abnormal protein aggregation.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20187243     DOI: 10.1002/mds.22721

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  28 in total

1.  Natural toxins implicated in the development of Parkinson's disease.

Authors:  Mohamed Salama; Oscar Arias-Carrión
Journal:  Ther Adv Neurol Disord       Date:  2011-11       Impact factor: 6.570

Review 2.  Intranasal administration of neurotoxicants in animals: support for the olfactory vector hypothesis of Parkinson's disease.

Authors:  Rui D S Prediger; Aderbal S Aguiar; Filipe C Matheus; Roger Walz; Layal Antoury; Rita Raisman-Vozari; Richard L Doty
Journal:  Neurotox Res       Date:  2011-10-15       Impact factor: 3.911

3.  The association between Mediterranean diet adherence and Parkinson's disease.

Authors:  Roy N Alcalay; Yian Gu; Helen Mejia-Santana; Lucien Cote; Karen S Marder; Nikolaos Scarmeas
Journal:  Mov Disord       Date:  2012-02-07       Impact factor: 10.338

4.  Characterizing dysbiosis of gut microbiome in PD: evidence for overabundance of opportunistic pathogens.

Authors:  Zachary D Wallen; Mary Appah; Marissa N Dean; Cheryl L Sesler; Stewart A Factor; Eric Molho; Cyrus P Zabetian; David G Standaert; Haydeh Payami
Journal:  NPJ Parkinsons Dis       Date:  2020-06-12

5.  Susceptibility to a parkinsonian toxin varies during primate development.

Authors:  B A Morrow; R H Roth; D E Redmond; S Diano; J D Elsworth
Journal:  Exp Neurol       Date:  2012-02-14       Impact factor: 5.330

6.  Dopamine and paraquat enhance α-synuclein-induced alterations in membrane conductance.

Authors:  Li Rebekah Feng; Kathleen A Maguire-Zeiss
Journal:  Neurotox Res       Date:  2011-07-07       Impact factor: 3.911

7.  The α7 nicotinic receptor agonist ABT-107 protects against nigrostriatal damage in rats with unilateral 6-hydroxydopamine lesions.

Authors:  Tanuja Bordia; Matthew McGregor; Roger L Papke; Michael W Decker; J Michael McIntosh; Maryka Quik
Journal:  Exp Neurol       Date:  2014-09-28       Impact factor: 5.330

Review 8.  Potential Therapeutic Application for Nicotinic Receptor Drugs in Movement Disorders.

Authors:  Maryka Quik; James T Boyd; Tanuja Bordia; Xiomara Perez
Journal:  Nicotine Tob Res       Date:  2019-02-18       Impact factor: 4.244

Review 9.  Nocardia asteroides-Induced movement abnormalities in mice: Relevance for Parkinson's disease?

Authors:  David A Loeffler; Peter A LeWitt; Dianne M Camp
Journal:  Mov Disord       Date:  2016-07-14       Impact factor: 10.338

10.  Dietary and lifestyle variables in relation to incidence of Parkinson's disease in Greece.

Authors:  Andreas Kyrozis; Apostolia Ghika; Panayiotis Stathopoulos; Dimitris Vassilopoulos; Dimitrios Trichopoulos; Antonia Trichopoulou
Journal:  Eur J Epidemiol       Date:  2013-02-02       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.